TR200003414T2 - Anti-viral terkipler - Google Patents

Anti-viral terkipler

Info

Publication number
TR200003414T2
TR200003414T2 TR2000/03414T TR200003414T TR200003414T2 TR 200003414 T2 TR200003414 T2 TR 200003414T2 TR 2000/03414 T TR2000/03414 T TR 2000/03414T TR 200003414 T TR200003414 T TR 200003414T TR 200003414 T2 TR200003414 T2 TR 200003414T2
Authority
TR
Turkey
Prior art keywords
viruses
viral compositions
virus
picona
coxaci
Prior art date
Application number
TR2000/03414T
Other languages
English (en)
Turkish (tr)
Inventor
Ezquerra-Carrera Jesus
Michael Gruber Joseph
Hamdouchi Hamdouchi Chaf�G
Elmer Holmes Richard
Alfred Spitzer Wayne
Original Assignee
Eli Lilly And Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly And Company filed Critical Eli Lilly And Company
Publication of TR200003414T2 publication Critical patent/TR200003414T2/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/437Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/444Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring heteroatom, e.g. amrinone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pyridine Compounds (AREA)
TR2000/03414T 1998-05-20 1998-05-20 Anti-viral terkipler TR200003414T2 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US1998/010299 WO1999059587A1 (en) 1998-05-20 1998-05-20 Anti-viral compounds

Publications (1)

Publication Number Publication Date
TR200003414T2 true TR200003414T2 (tr) 2001-03-21

Family

ID=22267098

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2000/03414T TR200003414T2 (tr) 1998-05-20 1998-05-20 Anti-viral terkipler

Country Status (15)

Country Link
EP (1) EP1077701A4 (cs)
JP (1) JP2002515433A (cs)
KR (1) KR20010025055A (cs)
CN (1) CN1292697A (cs)
AU (1) AU7583098A (cs)
BR (1) BR9815899A (cs)
CA (1) CA2332403A1 (cs)
CZ (1) CZ289425B6 (cs)
EA (1) EA200001208A1 (cs)
HU (1) HUP0102117A2 (cs)
IL (1) IL139166A0 (cs)
NO (1) NO20005795L (cs)
SK (1) SK17482000A3 (cs)
TR (1) TR200003414T2 (cs)
WO (1) WO1999059587A1 (cs)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPR213700A0 (en) 2000-12-18 2001-01-25 Biota Scientific Management Pty Ltd Antiviral agents
AR048650A1 (es) * 2004-05-04 2006-05-10 Tibotec Pharm Ltd Derivados de (1,10b-dihidro-2-(aminocarbonil-fenil)-5h-pirazolo[1,5 c][1,3]benzoxazin-5-il)fenil metanona como inhibidores de la replicacion viral del vih
ES2343640T3 (es) 2004-08-12 2010-08-05 Amgen Inc. Bisaril-sulfonamidas.
US7666880B2 (en) 2005-03-21 2010-02-23 S*Bio Pte Ltd. Imidazo[1,2-A]pyridine derivatives: preparation and pharmaceutical applications
WO2006101455A1 (en) * 2005-03-21 2006-09-28 S*Bio Pte Ltd Imidazo[1,2-a]pyridine derivatives: preparation and pharmaceutical applications
EP1971611B1 (en) 2005-12-21 2012-10-10 Abbott Laboratories Anti-viral compounds
JP2009521479A (ja) 2005-12-21 2009-06-04 アボット・ラボラトリーズ 抗ウイルス化合物
CA2633760A1 (en) 2005-12-21 2007-07-05 Abbott Laboratories Anti-viral compounds
CA2672737A1 (en) 2006-12-20 2008-11-06 Abbott Laboratories Anti-viral compounds
CA2725618C (en) * 2008-05-27 2016-04-12 Biota Scientific Management Pty Ltd Antiviral salts
EP2367824B1 (en) 2008-12-23 2016-03-23 AbbVie Inc. Anti-viral derivatives of pyrimidine
CN102245604A (zh) 2008-12-23 2011-11-16 雅培制药有限公司 抗病毒化合物
WO2010120935A1 (en) * 2009-04-15 2010-10-21 Abbott Laboratories Anti-viral compounds
WO2014060381A1 (de) 2012-10-18 2014-04-24 Bayer Cropscience Ag Heterocyclische verbindungen als schädlingsbekämpfungsmittel
JP2016503395A (ja) 2012-10-31 2016-02-04 バイエル・クロップサイエンス・アクチェンゲゼルシャフト 病害生物防除剤としての複素環化合物
CN104370732B (zh) * 2014-01-26 2015-08-19 山东信立泰药业有限公司 一种氯吡格雷及其中间体的制备方法
CN109535405B (zh) * 2017-09-21 2021-07-30 宁波聚嘉新材料科技有限公司 一种基于2-(4-羧基苯基)-5-羟基吡啶并咪唑的聚芳酯的制备方法
CN109810085B (zh) * 2019-04-19 2019-07-19 上海皓元生物医药科技有限公司 Acc抑制剂及其中间体的制备方法
CN110746450A (zh) * 2019-09-17 2020-02-04 济南康和医药科技有限公司 一种贝前列素钠关键中间体的合成方法
CN117902992A (zh) * 2024-01-04 2024-04-19 浙江永太科技股份有限公司 一种2,4-二氟苯基甘氨酸的制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4096264A (en) * 1975-12-09 1978-06-20 Merck & Co., Inc. Certain substituted imidazo [1,2-a] pyridines
US4250174A (en) * 1979-05-02 1981-02-10 Merck & Co., Inc. 3-Substituted imidazo [1,2-A] pyridines
US5693661A (en) * 1995-06-07 1997-12-02 Eli Lilly And Company Anti-viral compounds
US5891874A (en) * 1996-06-05 1999-04-06 Eli Lilly And Company Anti-viral compound
JP2000511899A (ja) * 1996-06-05 2000-09-12 イーライ・リリー・アンド・カンパニー 抗―ウイルス性化合物群
US5821242A (en) * 1996-06-06 1998-10-13 Eli Lilly And Company Anti-viral compounds

Also Published As

Publication number Publication date
SK17482000A3 (sk) 2005-03-04
EA200001208A1 (ru) 2001-06-25
NO20005795D0 (no) 2000-11-16
IL139166A0 (en) 2001-11-25
HUP0102117A2 (hu) 2001-12-28
CN1292697A (zh) 2001-04-25
BR9815899A (pt) 2001-02-20
EP1077701A4 (en) 2002-03-20
AU7583098A (en) 1999-12-06
EP1077701A1 (en) 2001-02-28
WO1999059587A1 (en) 1999-11-25
NO20005795L (no) 2001-01-18
CA2332403A1 (en) 1999-11-25
CZ289425B6 (cs) 2002-01-16
JP2002515433A (ja) 2002-05-28
CZ20004278A3 (en) 2001-05-16
KR20010025055A (ko) 2001-03-26

Similar Documents

Publication Publication Date Title
TR200003414T2 (tr) Anti-viral terkipler
EA200300023A1 (ru) 3'-ПРОЛЕКАРСТВА 2'-ДЕЗОКСИ-β-L-НУКЛЕОЗИДОВ
TR200200579T2 (tr) Amino-tirazolpiridin türevleri.
TW200730478A (en) N-(6-membered aromatic ring)-amido anti-viral compounds
MEP24608A (en) Azetidine derivatives, preparation thereof and pharmaceutical compositions containing same
HUP0101999A2 (hu) 4-Hidroxi-kinolin-3-karboxamid- és -hidrazid-származékok, ezeket tartalmazó gyógyászati készítmények, valamint e vegyületek alkalmazása
ATE203515T1 (de) Meta-substituierte phenylsulphonamidderivate
ATE231149T1 (de) (1,8)-naphthyridinderivate derivate mit antiviraler wirkung
TW200730476A (en) N-(5-membered aromatic ring)-amido anti-viral compounds
MX2007004783A (es) Inhibidores de la proteasa del virus de la hepatitis c, y composiciones y tratamientos que los usan.
EA200100838A1 (ru) Конъюгаты гксф
GB0201179D0 (en) Therapeutic agents
TR200100438T2 (tr) Hepatit C inhibitörü peptitler
DE69818094D1 (de) Antivirale verbindungen
EA200200374A1 (ru) Производные хинолилпропилпиперидина, их получение и содержащие их композиции
CY1112108T1 (el) Αναστολεις ιου ηπατιτιδας c
DK1169298T3 (da) Farmaceutiske forbindelser
NO954072D0 (no) Vannopplöselige camptotecinderivater, fremgangsmåte for deres fremstilling og deres anvendelse som antitumormidler
EA200100983A1 (ru) Производные 13-метилэритромицина
EP1230925A4 (en) ANTI-HIV COMPOSITIONS
ATE240339T1 (de) Nukleotidanaloga
EA200000431A2 (ru) Новые замещенные димерные соединения, способ их получения и фармацевтические композиции, содержащие их
PT781126E (pt) Derivados de 2-amino-1,2,3,4-tetra-hidro naftalino activos no sistema cardiovascular
ATE56006T1 (de) Succinimide derivate, herstellung und anwendung.
DE60005517D1 (de) Kaliumkanal-blockierende mittel